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The transgenic (Tg) mice carrying the human gene for poliovirus receptor (PVR) are susceptible to poliovirus intravenously
(IV) inoculated as well as intracerebrally or intraspinally inoculated. Thus, IV-inoculated poliovirus may invade the central
nervous system (CNS) through the blood–brain barrier (BBB). To know the contribution of PVR to tissue distribution and
BBB permeability of IV-inoculated polioviruses, these dissemination processes were investigated and compared between
the Tg mice and non-Tg mice. Distribution profile of IV-inoculated poliovirus in various tissues of the Tg mice is similar to
that in non-Tg mice. The data suggest that tissue distribution of the virus occurs independently of the transgene for PVR.
The amount of poliovirus delivered to the CNS suggested the existence of a specific delivery system of the virus to the
CNS. Virus accumulation in the CNS of the Tg mice was measured up to 7.5 hr after the IV inoculation. The viruses,
regardless of whether the virulent or attenuated strain, seem to accumulate at a constant rate of approximately 0.2 ml/
min/g tissue. Similar phenomena were observed when the viruses were inoculated into non-Tg mice. The rates of the virus
accumulation in the CNS are more than 100 times higher than that of albumin, which is considered not to permeate through
the BBB via a specific transport system, and only three times lower than that of monoclonal antibody against transferrin
receptor (OX-26), which is a potential candidate as a drug delivery vehicle specific to the CNS. These data suggest that
polioviruses permeate through the BBB at a fairly high rate, independently of PVR and virus strains. q 1997 Academic Press
INTRODUCTION by primary multiplication in the alimentary mucosa. After
viral multiplication in tissues such as the tonsils and
Poliovirus, known to be the causative agent of poliomy-
Peyer’s patches, the virus moves into the deep cervical
elitis, is a human enterovirus that belongs to the family
and mesenteric lymph nodes and then into the blood. If
Picornaviridae and is classified into three stable sero-
viremia is established, the virus invades the central ner-
types, 1, 2, and 3. The poliovirion is an icosahedral, non-
vous system (CNS) and paralytic poliomyelitis occurs as
enveloped particle that is composed of 60 copies of each
a result of the destruction of neurons in the CNS, espe-
of four capsid proteins, VP1, VP2, VP3, and VP4, and a
cially the motor neurons in the anterior horn of the spinal
single-stranded RNA genome of positive polarity. The
cord and neurons of the motor cortex and brain stem.three-dimensional structure of the virion particle (Hogle
Although many tissues are exposed to the virus duringet al., 1985) as well as the primary structures of the
the viremic phase, most tissues do not support poliovirusRNA genome and the viral proteins (Kitamura et al., 1981;
replication. Thus poliovirus seems to have a distinct tro-Racaniello and Baltimore, 1981) have been elucidated.
pism with regard to tissues and cell types. Little is known,The three-dimensional structure has revealed depres-
however, about mechanisms for the virus disseminationsions called ‘‘canyon’’ on the surface of the virion, which
characteristic of poliovirus.have been suggested to be attachment sites for poliovi-
Humans are the only natural host of poliovirus, al-rus receptor (PVR) on the surface of permissive cells.
though poliovirus can be experimentally transferred toThe life cycle of poliovirus was first described in the
monkeys, in which it also causes a paralytic disease.1950s (Bodian, 1955; Sabin, 1956). Poliovirus infection is
Other animal species are not susceptible to most poliovi-initiated by oral ingestion of the virus, which is followed
rus strains. Because of the characteristic species speci-
ficity of poliovirus, monkeys have been used as the only
1 Present address: Department of Pharmaceutics, Faculty of Pharma- animal model for poliomyelitis, and inoculation of the
ceutical Sciences, Tohoku University, Aoba, Aramaki-aza, Aoba-ku,
virus into the monkey CNS has been the only method toSendai 980-77, Japan.
evaluate neurovirulence levels of poliovirus.2 To whom correspondence and reprint requests should be ad-
dressed. Fax: 81-3-5449-5408. E-mail: anomoto@ims.u-tokyo.ac.jp. The virus-specific tropism must be controlled by host
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factors that support the virus replications. Among these All mice used were free from specific pathogens. ICR
mice were purchased from Charles River Japan (Tokyo)host factors, a specific cell surface receptor is consid-
ered to be one of the most important factors that deter- and used as non-Tg mice.
mine host range of the virus. Indeed, the transgenic (Tg)
Viruses and cellsmice carrying the human PVR gene were shown to be
susceptible to all three poliovirus serotypes, and the in- The virulent Mahoney virus (PV1(M)OM) and the atten-
uated Sabin 1 virus (PV1(Sab)IC-0) were derived fromfected mice showed clinical signs resemble those of hu-
mans and monkeys (Ren et al., 1990; Koike et al., 1991). infectious cDNA clones pOM1 (Shiroki et al., 1995) and
pVS(1)IC-0(T) (Kohara et al., 1988), respectively. VirusesIn the CNS of the infected Tg mice, poliovirus antigens
were detected only in neurons, and neuronal damages PV1(M)OM and PV1(Sab)IC-0 are termed MMM and SSS,
respectively, in this study. A cDNA segment of pOM1were observed (Koike et al., 1991, 1994b; Ren and Raca-
niello, 1992a; Horie et al., 1994). Clinical and pathological corresponding to a coding sequence for the viral capsid
proteins (P1 region) was replaced by the correspondingsimilarities of poliovirus infection in the Tg mice to those
in monkeys suggest that the Tg mice become an addi- segment of pVS(1)IC-0(T). A recombinant cDNA clone
thus obtained was used for transfection to prepare virustional animal model for poliomyelitis (Horie et al., 1994).
To control poliomyelitis, attenuated poliovirus strains MSM. A similar experiment was carried out to produce
virus SMS, whose genome had a reciprocal structure ofof all three serotypes have been developed and effec-
tively used as oral live poliovirus vaccines, that is, Sabin the MSM genome.
Suspension-cultured HeLa S3 cells were maintained1 (serotype 1), Sabin 2 (serotype 2), and Sabin 3 (serotype
3) (Sabin and Boulger, 1973). They have a very poor ca- in RPMI 1640 medium supplemented with 5% newborn
calf serum (NCS) and used for preparation of viruses.pacity to replicate in the CNS of monkeys and show a
very weak monkey neurovirulence, whereas the virulent African green monkey kidney (AGMK) cells were grown
in Dulbecco modified Eagle medium supplemented withstrains replicate well in the CNS and show a strong mon-
key neurovirulence. The virulent and attenuated pheno- 5% NCS and used for the transfection experiment with
infectious cDNA clones and for plaque assays.types of poliovirus observed in monkeys appeared to be
preserved in the Tg mice, since much larger doses of
Purification of virusesvirus were required for the attenuated strains to cause
paralysis compared with those of the virulent strains. In Viruses were grown in suspension-cultured HeLa cells
as described previously (Kajigaya et al., 1985). Virusesfact, relative neurovirulence levels of polioviruses esti-
mated in the Tg mice showed a good correlation with in cytoplasmic extracts of infected cells were purified by
chromatography on DEAE-Sepharose CL-6B (Li et al.,those in monkeys (Horie et al., 1994). The mouse neurovi-
rulence tests involving intracerebral (IC) and intraspinal 1992), followed by two cycles of CsCl equilibrium centrif-
ugation in a buffer containing 10 mM Tris–HCl (pH 7.4),(IS) inoculation routes have been established to date
(Horie et al., 1994; Abe et al., 1995a; 1995b). 10 mM NaCl, 20 mM EDTA, and 1% Brij 58. For prepara-
tion of [35S]methionine-labeled viruses, viruses wereDifferent neurovirulence levels are also observed be-
tween the virulent and attenuated poliovirus strains when grown in methionine-free medium in the presence of
[35S]methionine. Calculated specific radioactivities of pu-the viruses are intravenously (IV)-inoculated into the Tg
mice (Koike et al., 1994b). Using this inoculation route, rified radiolabeled Mahoney and Sabin 1 viruses were
148 and 27 mCi/nmol, respectively.we investigate dissemination of poliovirus from the blood
stream to the CNS of the Tg and non-Tg mice. Our data
Clinical neurovirulence testsindicate that tissue distribution of the virus occurs inde-
pendently of human PVR. Furthermore, we show that IV- Into the brain or tail vein of each Tg mouse, 30 or 200
ml of a virus suspension was inoculated. More than 10inoculated poliovirus accumulates in various tissues of
the CNS, independently of human PVR, at a fairly high Tg mice were used for injection with each dose of viruses
except for experiments involving IC inoculation of SMSrate. The results suggest that poliovirus is able to perme-
ate through the blood–brain barrier (BBB) of mice without in which 5 Tg mice were used. The mice inoculated with
viruses were observed for clinical signs at 12-hr intervalsthe aid of human PVR.
up to 14 days. The 50% lethal doses (LD50) were calcu-
lated according to the Dragstehdt–Behrens method, aMATERIALS AND METHODS
modified Reed–Muench method (Finny, 1959). Approxi-
Transgenic mice
mate minimum 100% lethal doses (LD100) were also esti-
mated.The Tg mouse line ICR-PVRTg21 (Koike et al., 1991),
in the hemizygous stage of 8 to 10 weeks of age, was
Distribution of viruses in miceused as an animal model for poliomyelitis. The copy num-
ber of the transgene in ICR-PVRTg21 is approximately Male Tg mice and non-Tg mice weighing 28–35 g
were used. The animals had free access of food andthreefold that in HeLa S3 cells (Koike et al., 1991; 1994a).
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water. Each mouse was inoculated with 2.5 1 1002 pmol
of viruses (approximately 6.5 1 106 PFU) containing 0.4
mCi of labeled viruses via tail vein under mild ether anes-
thesia. [125I]albumin was used as a control compound
that was known to exhibit significantly restricted BBB
permeability. Three mice were dissected 5 hr after the
inoculation. The tissues were weighed, minced, and dis-
solved with a tissue solubilizer, Solvable (Dupont, U.S.A.),
FIG. 1. Genome structures of recombinant type 1 polioviruses. The
at 507 for 3hr, and then 10 ml of liquid scintillation cock- genome structures of the recombinant viruses are shown as a combina-
tail, Atomlight (Dupont), was added. Radioactivities were tion of the Mahoney (shadowed boxes) and the Sabin 1 (open boxes)
measured in a liquid scintillation counter (Aloka LSC- sequences. VPg at the 5* end and poly(A) at the 3* end are indicated
by closed circles and wavy lines. Numbers shown above the Mahoney1000). As an index of tissue distribution characteristics of
genome represent nucleotide numbers from the 5* terminus.poliovirus, the apparent tissue-to-plasma concentration
ratio, Kp,app , defined by amount of virus per grams of
brain, PS/Vbr , can be obtained from the initial slope of atissue divided by that per microliter of plasma, was calcu-
plot of Cbr(t)/Cp(t), i.e., Kp,app(t) vs AUC(0-t)/Cp(t), as integra-lated over the time period of the experiment (Terasaki et
tion plot.al., 1984). Least squares regression analysis was per-
formed with the program of Excel (Microsoft, U.S.A.). In
Separation of parenchyma and capillary fractions of
some cases, 2 nmol of monoclonal antibody (mAb)
the brain
against human PVR, p286, that had been prepared and
Parenchyma and capillary fractions of the brain werecharacterized by J. Aoki and found to have very similar
separated by a modified method of Triguero et al. (1990).characteristics to mAb p403 (Aoki et al., 1994), was intra-
Briefly, the brain was minced after removal of meningesvenously administered to Tg mice 5 hr before the virus
and connective tissues, added to 4 vol of physiologicinoculation. Kd value of p286 to human PVR on cell sur-
buffer containing 10 mM HEPES (pH 7.4), 141 mM NaCl,face was calculated to be 8 nM. According to the calcu-
4 mM KCl, 2.8 mM CaCl2 , 1 mM MgSO4 , 1 mM NaH2PO4 ,lated elimination rate constant of p286 in the mouse
and 10 mM D-glucose, and then homogenized in a teflonplasma, concentration of p286 5 hr after the virus inocula-
homogenizer with 10 strokes. The homogenate wastion should be about 80 nM and therefore still enough
added to an equal volume of 32% dextran solution andto inhibit virus binding to PVR.
homogenized with 3 more strokes. An aliquot of 0.2 mlTo know accumulation rate of viruses in various tis-
was used to estimate radioactivity and virus titer in asues of the mouse CNS, Kp,app values in these tissues
whole brain. The remaining homogenates were centri-were measured by the method of integration plot (Smith
fuged at 5400 g for 15 min at 47 in a Beckman rotor SW55et al., 1987; Kakee et al., 1996) up to 7.5 hr after the virus
to precipitate capillary fraction.inoculation. Briefly, the accumulation rate of poliovirus
To monitor the separation, the activity of alkaline phos-can be described by the following differential equation:
phatase, a marker enzyme for capillary fraction, was
measured (Triguero et al., 1990). For the same purpose,dXbr
dt
 PS 1 Cp (1) 125I-labeled acetylated low density lipoprotein was also
employed as a marker material that accumulated only inwhere Xbr is the amount of
35S-labeled poliovirus in the
capillary fraction (Triguero et al., 1990).brain at time t, PS is the brain accumulation rate, and
Cp is the plasma concentration of
35S-labeled poliovirus. Sucrose density gradient centrifugation
Integration of equation (1) gives 35S-labeled materials in parenchyma fraction of the
Xbr(t)  PS 1 AUC(0-t) / Cp(t) 1 V0 (2) brain was analyzed by centrifugation on 15–30% sucrose
density gradient in a buffer containing 0.1% bovine serum
where AUC(0-t) represents the area under the plasma
albumin and phosphate-buffered saline. The centrifuga-
concentration time curve of 35S-labeled poliovirus from
tion was performed at 200,000 g for 2.5 hr at 47 in a
time 0 to t, and V0 is the rapidly equilibrated distribution Beckman rotor SW41.
volume of 35S-labeled poliovirus. Equation (2) divided by
Cp(t) 1 Vbr gives RESULTS
Mouse neurovirulence tests on virusesCbr(t)
Cp(t)
 SPSVbrD 1 AUC(0-t)Cp(t) / V0Vbr (3) The virulent Mahoney strain (MMM), attenuated Sabin
1 strain (SSS), and their recombinant viruses (MSM and
SMS) were prepared as described under Materials andwhere Vbr represents the brain weight, and Cbr(t) is the
brain concentration of 35S-labeled poliovirus. The brain Methods. The genome structures of these viruses are
shown in Fig. 1. The viruses were tested for their neurovi-accumulation rate of 35S-labeled poliovirus per grams of
AID VY 8450 / 6a2c$$$$42 02-27-97 10:48:24 vira AP: Virology
424 YANG ET AL.
TABLE 1 know the amount of virus delivered to individual tissues
including the brain tissues, we took advantage of physio-LD50 and Approximate Minimum LD100 of Poliovirus in Tg Mouse
logical pharmacokinetic analysis as described under Ma-
terials and Methods (Terasaki et al., 1984). Tissue distri-LD50 Minimum LD100
(PFU/mouse) (PFU/mouse) bution of MMM, SSS, or MSM in Tg mice or non-Tg mice
was examined 5 hr after the IV inoculation. The result of
Virus IVa ICb IVa ICb MSM distribution is shown in Fig. 2A. Similar results
were obtained for MMM and SSS distributions (data notMMM 8.5 1 104 2.1 1 102 4.0 1 106 1.0 1 104
shown).SSS — 7.0 1 105 — 7.0 1 107
MSM 3.2 1 105 4.2 1 102 6.0 1 106 4.0 1 104 Amounts of poliovirus delivered to the CNS including
SMS — 1.3 1 105 — #8.4 1 107 the cerebrum and cerebellum are the smallest among
all tissues tested. However, Kp,app values in the cerebruma Intravenous inoculation.
and cerebellum are more than 200 ml/g tissue, and areb Intracerebral inoculation.
significantly greater than the vascular volume of the
brain, i.e., about 10 ml/g tissue (Pardridge et al., 1990;
rulence in the Tg mice via IC and IV inoculation routes. 1991). The data may suggest that polioviruses cross the
The results are shown by values of LD50 and approximate blood–brain barrier.
values of minimum LD100 in Table 1. A similar in vivo distribution characteristic of circulat-
Viruses MMM and SSS showed the strongest and ing poliovirus was obtained when non-Tg mice was used.
weakest neurovirulence among the viruses, respectively, The data shown in Fig. 2A suggest that the Kp,app values
when the mice were IC-inoculated (Table 1). Neuroviru- obtained from experiments with Tg mice and non-Tg
lence levels of viruses MSM and SMS are similar to mice have a good correlation with each other on a level
those of MMM and SSS, respectively, although MSM of P  0.01 (correlation coefficient: r 2  0.903; n  9).
appears to be slightly weaker than MMM and SMS This suggests that specific distributions of poliovirus to
slightly stronger than SSS. Thus, virion surface character- the brain tissues are not due to specific expression of
istics had little or no correlation with mouse neuroviru- human PVR on the brain capillary. To confirm this possi-
lence. This observation is compatible with our previous bility, Tg mice were IV-injected with anti-PVR mAb p286
results obtained from monkey tests (Omata et al., 1986; 5 hr before the virus inoculation as described under Ma-
Kohara et al., 1988) and Tg mouse tests (Horie et al., terials and Methods. This mAb has an ability to block
1994). Similar results were obtained when the mice were human PVR-mediated poliovirus binding and infection to
IV-inoculated with MMM and MSM although much larger susceptible cells. As shown in Fig. 2B, preadministration
amounts of viruses were required to cause paralysis and of p286 appears not to affect the differential tissue distri-
death (Table 1). In the case of IV inoculation, however, bution of poliovirus. The Kp,app values again have a good
it took at least one more day for the mice to be killed as correlation with each other on a level of P 0.01 (correla-
compared with the case of IC inoculation. LD50 values of tion coefficient: r 2  0.981; n  9). A similar result was
SSS and SMS could not be calculated because no mice obtained from the experiment involving MMM. These re-
sults indicate that human PVR expressed in the mousewere killed even by IV inoculating 1 1 108 PFU of these
tissues does not play any significant role for the differen-viruses.
tial tissue distribution of poliovirus.Approximate values of minimum LD100 were estimated
and are shown in Table 1. The LD100 values obtained
from the experiments involving IV inoculation of MMM
and MSM were 150 to 400 times more than those involv-
ing IC inoculation of these viruses. Main dissemination
route of poliovirus from blood to the CNS is not known
at present. However, if circulating virus invades the brain
at first as suggested (Koike et al., 1994b; Nomoto et al.,
1994), the data suggest that 0.25–0.6% of IV-inoculated
virus has to invade the brain to kill all the mice. Consider-
ing the fact that approximately 0.3% of a total amount of
IV-inoculated virus is distributed to the cerebrum, most
FIG. 2. Tissue distribution of poliovirus in mice after IV inoculation.
of the virus distributed should move into the brain. (A) Kp,app values of [35S]methionine-labeled MSM in various tissues were
calculated in Tg mice (vertical axis) and non-Tg mice (horizontal axis)
Tissue distribution of IV-inoculated virus 5 hr after the IV inoculation. (B) Tg mice were IV-injected with mAb
p286 5 hr before the IV inoculation of [35S]methionine-labeled MSM as
It is possible that IV-inoculated poliovirus is delivered described under Materials and Methods. Kp,app values of MSM in vari-
selectively to the CNS. Expression of human PVR may ous tissues were calculated in Tg mice (vertical axis) and Tg mice
pretreated with the mAb (horizontal axis) 5 hr after the IV inoculation.contribute to the virus delivery after IV inoculation. To
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non-Tg mice. It is possible that the Sabin 1 capsid has
a slightly higher efficiency in the virus accumulation in
the cerebrum as compared with the virulent Mahoney
capsid. It should be noted that the accumulation rates
observed for polioviruses are more than 100 times higher
compared with that of albumin (Table 2), which is known
to exhibit significantly restricted permeability across the
BBB and are only three times less than that of anti-trans-
ferrin receptor mAb, OX-26, which has been considered
as a potential candidate of the drug delivery vehicle spe-
cific to the CNS (Pardridge et al., 1991) (Table 2). Accumu-
lation rate of cationized rat serum albumin, which is
known to have an efficient BBB permeability (Pardridge
et al., 1990), is similar to those of polioviruses (Table 2).
These data strongly suggest that polioviruses permeate
the BBB at a fairly high rate, independently of PVR and
virus strains.
FIG. 3. Integration plot of poliovirus Mahoney strain in the CNS of
Tg mice after IV inoculation. Tg mice were IV-inoculated with [35S]-
State of poliovirus in the CNSmethionine-labeled MMM as described under Materials and Methods.
Average Kp,app values in the cerebrum (A), cerebellum (B), brain stem Since the possible permeation of poliovirus through
(C), and spinal cord (D) were calculated at indicated AUC/Cp values.
the BBB is not mediated by human PVR, which is consid-Three Tg mice were used for injection at each time. Calculation of
ered to be the essential cellular molecule for establish-AUC/Cp values followed that reported by Smith et al. (1987).
ment of the virus infection (Mendelsohn et al., 1989; Koike
et al., 1990), it is possible that intact infectious poliovirus
Rate of poliovirus accumulation in the CNS particles exist in parenchyma fraction of the brain. Ac-
cordingly, a modified method of Triguero et al. (1990)
To know the rate of poliovirus accumulation from the was employed to separate the parenchyma fraction from
circulating blood to the CNS, Tg mice were IV-inoculated capillary fraction as described under Materials and Meth-
with 35S-labeled MMM, and the time course of virus accu- ods. As shown in Table 3, about 10% of a total activity
mulation in individual tissues of the CNS followed up to of alkaline phosphatase (a marker enzyme for capillary)
7.5 hr after the inoculation when the virus replication was was still detected in parenchyma fraction. A similar purity
not yet detected in any of these tissues. Experiments was estimated when distribution of acetylated low den-
were repeated three times for MMM and SSS and twice sity lipoprotein was examined after the IV administration.
for MSM. The results are shown in Fig. 3 by integration Tg mice or non-Tg mice were inoculated with 35S-la-
plot (Smith et al., 1987; Kakee et al., 1996). Standard beled MMM or 35S-labeled SSS. The brain homogenates
errors were too small to show in Fig. 3. Slopes shown were prepared at times indicated in Fig. 4 and separated
in Fig. 3 represent virus accumulation rates in individual into parenchyma and capillary fractions. After the separa-
tissues. Linear accumulation of the virus was observed tion, about 90% of a total 35S-labeled materials in the
in any these tissues up to 7.5 hr after the inoculation. brain were recovered in parenchyma fraction (Fig. 4).
The rates were estimated to be 0.164, 0.171, 0.151, and
0.117 ml/min/g tissue in the cerebrum, cerebellum, brain
stem, and spinal cord, respectively. In other tissues, lin- TABLE 2
ear accumulation was not seen, and the rates are coming
Accumulation Rate of Poliovirus into the Mouse Cerebrum
to plateaus during the time used (data not shown). Similar
experiments were carried out on the cerebrum by using Accumulation rate (ml/min/g tissue)
non-Tg mice and/or viruses carrying the Sabin 1 capsid
Virus or control material Tg mouse Non-Tg mouseto know the contribution of human PVR and virion surface
characteristics to accumulation rates of viruses. As
MMM 0.164 0.123
shown in Table 2, the rates observed in Tg mice resem- SSS 0.223 0.246
ble those in non-Tg mice. Thus, human PVR seems not MSM 0.268 —
Albumin — 0.001to play an important role in delivery of circulating poliovi-
OX-26a 0.65 (Rat)rus to the cerebrum.
Cationized RSAb 0.123 (Rat)The accumulation rates of SSS and MSM were esti-
mated to be 0.223 and 0.268 ml/min/g tissue in Tg mice a Monoclonal antibody against transferrin receptor (Pardridge et al.,
and are slightly higher than that (0.164 ml/min/g tissue) 1991).
b Cationized rat serum albumin (Pardridge et al., 1990).of MMM (Table 2). A similar observation was seen in
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TABLE 3
Comparison of Alkaline Phosphatase Activity and Kp,app of
125I-Acetylated-LDL between Capillary and Parenchyma Fraction




(parenchyma rich) 10.5 { 0.1 1.67 { 0.01
Pellet (capillary rich) 69.1 { 2.5 14.4 { 0.02
Supernatant/total 0.132 { 0.007 0.104 { 0.002
FIG. 5. Analysis of radioactive materials by sucrose density gradient
Note. Four mice were used for each experiment. centrifugation. Radioactive materials recovered from the cerebrum of
Tg mice (l—l) or non-Tg mice (s- - -s) 7.5 hr after the IV inoculation of
35S-labeled MMM were analyzed by centrifugation on sucrose densityThese suggest that most polioviruses in the brain exist gradients as described under Materials and Methods. Positions of
in parenchyma fraction, although it is possible that some intact virion (160S) and poliovirus-related particles (135S and 80S) dur-
viruses associated to the capillary fraction are detached ing the uncoating process are indicated by arrows.
from capillary during centrifugation and recovered in pa-
renchyma fraction.
pharmacokinetic analysis in addition to virological tech-To know whether 35S-labeled materials recovered in the
niques. Amount of virus in plasma is changing with timeparenchyma fraction at 7.5 hr after the inoculation are intact
after the virus inoculation because of trapping virusesvirion particles, the radiolabeled materials were analyzed
by tissues and degradation of virion particles. Further-by centrifugation on sucrose density gradients. As shown
more, in Tg mice, inoculated virus may multiplicate inin Fig. 5, the majority of radioactivities was associated to
some susceptible tissues and leak to the blood stream,materials at a sedimentation constant of 160S, a position
although this phenomenon was not seen in the miceof intact virion particle. The data indicate that 35S-labeled
during the time period used in this study. These factorsmaterials in parenchyma fraction of the brain tissue contain
must affect virus concentration in plasma, resulting inintact poliovirus particles. Indeed, this fraction showed a
alteration on pressure for virus transport from the bloodplaque forming activity (data not shown).
stream to individual tissues. This difficulty in studying
DISCUSSION virus distribution was overcome in this study by em-
Distribution and dissemination of IV-inoculated poliovi- ploying Kp,app value, apparent tissue-to-plasma concen-
rus in Tg and non-Tg mice were studied by means of tration ratio (Terasaki et al., 1984), which is also termed
as tissue distribution volume (Pardridge et al., 1990).
Instability of poliovirus differs in virus strains. Viruses
carrying the Sabin 1 capsid (SSS and MSM) are less
stable than those carrying the Mahoney capsid (MMM
and SMS) in the brain of non-Tg mice (data not shown).
This observation is compatible with previous results re-
ported by Koike et al. (1991). Difference in virion stabili-
ties must be one of determinants for neurovirulence phe-
notype.
It was shown that poliovirus accumulated and proba-
bly permeated into various tissues of the mouse CNS
such as the cerebrum, cerebellum, brain stem, and spinal
cord (Fig. 3). The main dissemination route for causing
the disease, however, is not clarified yet. To the cere-
brum and spinal cord, approximately 0.3 and 0.09% of a
total amount of inoculated virus were distributed, respec-
tively, at 5 hr after the inoculation when the absolute
FIG. 4. Radioactivities in parenchyma and capillary fractions of the quantity of virus almost plateaued. Although the amount
cerebrum. Five Tg mice (A and C) or five non-Tg mice (B and D) were of delivered virus was smaller in the spinal cord than the
inoculated with [35S]methionine-labeled MMM (A and B) or SSS (C and cerebrum, virus replication was detected in the spinal
D), and the cerebrum were separated into parenchyma and capillary
cord earlier than the cerebrum (data not shown). Thisfractions as described under Materials and Methods. Average Kp,app
might be explainable by different sensitivities of neuronsvalues with standard errors of radioactivities recovered in parenchyma
(l—l) and capillary (s- - -s) fractions were plotted at indicated times. to poliovirus between the two tissues. Indeed, the Tg
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mice is more sensitive to IS-inoculated poliovirus than used as an essentially BBB impermeable marker mole-
cule (Kakee et al., 1996), at 2, 48, and 72 hr after theIC-inoculated poliovirus. It has been reported that the
first tissue of the CNS where poliovirus replicates is the inoculation (data not shown). This indicates that the BBB
is not damaged by lytic replication of poliovirus at indi-brain after the oral administration of the virus to ICR-
PVRTg1 (Koike et al., 1994b; Nomoto et al., 1994). The cated times above. These data support the notion that
poliovirus permeates the BBB at a fairly high rate withoutdata appear not to be compatible with the observations
described above. Neurons of the brain of ICR-PVRTg1 the virus replication. If it is also true in humans, circulat-
ing poliovirus including the Sabin vaccine strains easilymice might be sensitive enough even to the small amount
of poliovirus that permeates to the cerebrum at a very invade the human CNS. Some host cellular molecules
other than PVR must be involved in the BBB permeabilityearly stage, whereas those of ICR-PVRTg21 mice require
a relatively larger amount of poliovirus for establishment of poliovirus. Molecular mechanisms for this dissemina-
tion process of poliovirus are now being investigated.of infection. It has been well-documented that ICR-PVR
Tg1 is more sensitive to poliovirus than ICR-PVRTg21
(Koike et al., 1994a). Thus, sensitivity of neurons and/or
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